Skadden Arps Slate Meagher & Flom and Freshfields Bruckhaus Deringer have taken lead roles on the global private placement of shares in German chemicals company Evonik ahead of its multibillion-euro initial public offering (IPO) on the Frankfurt Stock Exchange. Evonik – a cosmetics and food manufacturer – has seen around 12% of its shares placed with institutional investors since 22 February, in what is thought to be Germany's largest-ever pre-IPO capital markets financing. The move comes ahead of Evonik's planned float, which is reportedly set to value the company at around €14bn (£12bn).
March 21, 2013 at 08:03 PM
1 minute read
The original version of this story was published on Legalweek
Skadden Arps Slate Meagher & Flom and Freshfields Bruckhaus Deringer have taken lead roles on the global private placement of shares in German chemicals company Evonik ahead of its multibillion-euro initial public offering (IPO) on the Frankfurt Stock Exchange.
Evonik – a cosmetics and food manufacturer – has seen around 12% of its shares placed with institutional investors since 22 February, in what is thought to be Germany’s largest-ever pre-IPO capital markets financing.
Presented by BigVoodoo
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Javerbaum Wurgaft, a large civil litigation firm with nine (9) offices, seeks: Plaintiff Personal Injury Attorney for Northern New Jersey of...
Exciting Career Opportunities at Nuzzo & Roberts! Nuzzo & Roberts, a leading mid-sized insurance defense firm based in Cheshire, CT...
